Literature DB >> 28537576

An infant and mother with severe B12 deficiency: vitamin B12 status assessment should be determined in pregnant women with anaemia.

A Sobczyńska-Malefora1,2, R Ramachandran3, D Cregeen4, E Green4, P Bennett5, D J Harrington1,6, H A Lemonde3.   

Abstract

The vitamin B12 status of infants depends on maternal B12 status during pregnancy, and during lactation if breastfed. We present a 9-month-old girl who was admitted to the metabolic unit for assessment of developmental delay. She was exclusively breastfed and the introduction of solids at 5 months was unsuccessful. Investigations revealed pancytopenia, undetectable B12 and highly elevated methylmalonic acid and homocysteine. Methylmalonic acid and homocysteine normalised following B12 injections. Marked catch-up of developmental milestones was noted after treatment with B12. Investigations of parents showed normal B12 in the father and combined B12 and iron deficiency in the mother. Maternal B12 deficiency, most likely masked by iron deficiency, led to severe B12 deficiency in the infant. Exclusive breastfeeding and a subsequent failure to wean exacerbated the infant's B12 deficiency leading to developmental delay. This case highlights the need for development of guidelines for better assessment of B12 status during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28537576     DOI: 10.1038/ejcn.2017.85

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  9 in total

Review 1.  Cobalamin status in children.

Authors:  Anne-Lise Bjørke-Monsen; Per Magne Ueland
Journal:  J Inherit Metab Dis       Date:  2010-05-27       Impact factor: 4.982

Review 2.  Navigating the B(12) road: assimilation, delivery, and disorders of cobalamin.

Authors:  Carmen Gherasim; Michael Lofgren; Ruma Banerjee
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

3.  Is exclusive breastfeeding ensuring an optimal micronutrient status and psychomotor development in infants?

Authors:  Anne-Lise Bjørke-Monsen
Journal:  Clin Biochem       Date:  2014-05-17       Impact factor: 3.281

4.  Clinical presentation and metabolic consequences in 40 breastfed infants with nutritional vitamin B12 deficiency--what have we learned?

Authors:  Tomas Honzik; Miriam Adamovicova; Vratislav Smolka; Martin Magner; Eva Hruba; Jiri Zeman
Journal:  Eur J Paediatr Neurol       Date:  2010-01-20       Impact factor: 3.140

5.  Cobalamin status and its biochemical markers methylmalonic acid and homocysteine in different age groups from 4 days to 19 years.

Authors:  Anne-Lise Bjørke Monsen; Helga Refsum; Trond Markestad; Per Magne Ueland
Journal:  Clin Chem       Date:  2003-12       Impact factor: 8.327

6.  Common metabolic profile in infants indicating impaired cobalamin status responds to cobalamin supplementation.

Authors:  Anne-Lise Bjørke-Monsen; Ingrid Torsvik; Hege Saetran; Trond Markestad; Per Magne Ueland
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

7.  Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring.

Authors:  Michelle M Murphy; Anne M Molloy; Per M Ueland; Joan D Fernandez-Ballart; Jörn Schneede; Victoria Arija; John M Scott
Journal:  J Nutr       Date:  2007-08       Impact factor: 4.798

Review 8.  Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II.

Authors:  Ralph Carmel
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

9.  Motor development related to duration of exclusive breastfeeding, B vitamin status and B12 supplementation in infants with a birth weight between 2000-3000 g, results from a randomized intervention trial.

Authors:  Ingrid Kristin Torsvik; Per Magne Ueland; Trond Markestad; Øivind Midttun; Anne-Lise Bjørke Monsen
Journal:  BMC Pediatr       Date:  2015-12-18       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.